Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.

[1]  Alan S. Brown,et al.  The burden of familial chylomicronemia syndrome from the patients’ perspective , 2017, Expert review of cardiovascular therapy.

[2]  D. Rader,et al.  A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis , 2017, The Journal of clinical endocrinology and metabolism.

[3]  D. Gaudet,et al.  The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS). , 2017, Atherosclerosis.

[4]  S. Young,et al.  Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia , 2017, The New England journal of medicine.

[5]  J. Witztum,et al.  The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study , 2017, Expert review of cardiovascular therapy.

[6]  D. Gaudet,et al.  Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis. , 2016, Human gene therapy.

[7]  A. Garg,et al.  Type 1 Hyperlipoproteinemia Due to Compound Heterozygous Rare Variants in GCKR. , 2016, The Journal of clinical endocrinology and metabolism.

[8]  S. Young,et al.  GPIHBP1 and Plasma Triglyceride Metabolism , 2016, Trends in Endocrinology & Metabolism.

[9]  N. Rashid,et al.  Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system. , 2016, Journal of clinical lipidology.

[10]  G. Olivecrona.  Role of lipoprotein lipase in lipid metabolism , 2016, Current opinion in lipidology.

[11]  D. Gaudet,et al.  Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist , 2016 .

[12]  H. Nawaz,et al.  Elevated Serum Triglycerides are Independently Associated With Persistent Organ Failure in Acute Pancreatitis , 2015, The American Journal of Gastroenterology.

[13]  D. Gaudet,et al.  Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. , 2015, The New England journal of medicine.

[14]  R. Fresa,et al.  Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia. , 2015, Atherosclerosis.

[15]  R. Hegele,et al.  Chylomicronaemia—current diagnosis and future therapies , 2015, Nature Reviews Endocrinology.

[16]  R. Zechner,et al.  The tissue distribution of lipoprotein lipase determines where chylomicrons bind , 2015, Journal of Lipid Research.

[17]  D. Gaudet,et al.  Targeting APOC3 in the familial chylomicronemia syndrome. , 2014, The New England journal of medicine.

[18]  Z. Ahmad,et al.  Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. , 2014, Journal of clinical lipidology.

[19]  M. Lagarde,et al.  Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects , 2014, PloS one.

[20]  F. Blanco-Vaca,et al.  Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[21]  F. Sacks,et al.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.

[22]  R. Hegele,et al.  Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia , 2012, Journal of internal medicine.

[23]  Karine Tremblay,et al.  Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial , 2012, Gene Therapy.

[24]  G. Olivecrona,et al.  Apolipoprotein A-V; a potent triglyceride reducer. , 2011, Atherosclerosis.

[25]  D. Noto,et al.  Lipase maturation factor 1 is required for endothelial lipase activity[S] , 2011, Journal of Lipid Research.

[26]  A. Asghar,et al.  Standard Splenic Volume Estimation in North Indian Adult Population: Using 3D Reconstruction of Abdominal CT Scan Images , 2011, Anatomy research international.

[27]  Jianwu Xu,et al.  Computer-aided measurement of liver volumes in CT by means of geodesic active contour segmentation coupled with level-set algorithms. , 2010, Medical physics.

[28]  P. Walter,et al.  Lipase Maturation Factor LMF1, Membrane Topology and Interaction with Lipase Proteins in the Endoplasmic Reticulum* , 2009, The Journal of Biological Chemistry.

[29]  J. Heeren,et al.  Apoprotein A-V: An important regulator of triglyceride metabolism , 2008, Journal of Inherited Metabolic Disease.

[30]  D. Blom,et al.  Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[31]  P. Pajukanta,et al.  Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.

[32]  R. Hegele,et al.  Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650) , 2007, Lipids in Health and Disease.

[33]  K. Tsukamoto.  [Familial lipoprotein lipase deficiency]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[34]  Selvendran Sugandhan,et al.  Familial Chylomicronemia Syndrome , 2007, Pediatric dermatology.

[35]  C. Lam,et al.  Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[36]  L. Pennacchio,et al.  Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein Lipase* , 2005, Journal of Biological Chemistry.

[37]  S. Djurovic,et al.  Missense mutation W86R in exon 3 of the lipoprotein lipase gene in a boy with chylomicronemia. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[38]  C. Chiu,et al.  Mutations in the Lipoprotein Lipase Gene as a Cause of Hypertriglyceridemia and Pancreatitis in Taiwan , 2003, Pancreas.

[39]  J Auwerx,et al.  Mechanism of action of fibrates on lipid and lipoprotein metabolism. , 1998, Circulation.

[40]  M. Hayden,et al.  Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event. , 1998, American journal of medical genetics.

[41]  H. Brewer,et al.  Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[42]  J. Mössner,et al.  Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats , 1996, International Journal of Pancreatology.

[43]  M. Hayden,et al.  A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. , 1991, The New England journal of medicine.

[44]  G. Schonfeld,et al.  Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. , 1979, Metabolism: clinical and experimental.

[45]  J. Little,et al.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.

[46]  R. Lees,et al.  Editorial: A System for Phenotyping Hyperlipoproteinemia , 1965 .

[47]  A. George.  The metabolic basis of inherited disease , 1961 .

[48]  K. Lackner,et al.  Apolipoprotein A-V , 2019, Springer Reference Medizin.

[49]  E. Stroes,et al.  Diagnostic algorithm for familial chylomicronemia syndrome. , 2017, Atherosclerosis. Supplements.

[50]  T. Zima,et al.  Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene. , 2014, Folia biologica.

[51]  P. Talmud,et al.  Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy , 1997, Human mutation.

[52]  M. Raissaki,et al.  Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus , 1997, European Radiology.

[53]  G. Cerri,et al.  Sonographic assessment of normal spleen volume , 1995, Clinical anatomy.

[54]  Havel Rj.  Pathogenesis, differentiation and management of hypertriglyceridemia. , 1969 .

[55]  R. Havel.  Pathogenesis, differentiation and management of hypertriglyceridemia. , 1969, Advances in internal medicine.